HEADER TRANSFERASE 12-OCT-12 4HJ2 TITLE CRYSTAL STRUCTURE ANALYSIS OF GSTA1-1 IN COMPLEX WITH CHLORAMBUCIL COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTATHIONE S-TRANSFERASE A1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GST HA SUBUNIT 1, GST CLASS-ALPHA MEMBER 1, GST-EPSILON, COMPND 5 GSTA1-1, GTH1; COMPND 6 EC: 2.5.1.18; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GSTA1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ALPHA-BETA, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.KARPUSAS,L.CHINIADIS,N.E.LABROU REVDAT 2 28-FEB-24 4HJ2 1 REMARK REVDAT 1 27-MAR-13 4HJ2 0 JRNL AUTH M.KARPUSAS,I.AXARLI,L.CHINIADIS,A.PAPAKYRIAKOU,K.BETHANIS, JRNL AUTH 2 K.SCOPELITOU,Y.D.CLONIS,N.E.LABROU JRNL TITL THE INTERACTION OF THE CHEMOTHERAPEUTIC DRUG CHLORAMBUCIL JRNL TITL 2 WITH HUMAN GLUTATHIONE TRANSFERASE A1-1: KINETIC AND JRNL TITL 3 STRUCTURAL ANALYSIS. JRNL REF PLOS ONE V. 8 56337 2013 JRNL REFN ESSN 1932-6203 JRNL PMID 23460799 JRNL DOI 10.1371/JOURNAL.PONE.0056337 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.49 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 85.6 REMARK 3 NUMBER OF REFLECTIONS : 23318 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1838 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3490 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 298 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.39 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.50200 REMARK 3 B22 (A**2) : 4.62900 REMARK 3 B33 (A**2) : -2.12700 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 4.72200 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 28.13 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : CNS_TOPPAR:PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : 3CSH_ON_R1_ADUCT1_PRODRG.PARM REMARK 3 PARAMETER FILE 3 : CNS_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4HJ2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-OCT-12. REMARK 100 THE DEPOSITION ID IS D_1000075527. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-D REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23814 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.2 REMARK 200 DATA REDUNDANCY : 2.200 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.22900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 49.50000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.76500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 49.50000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 46.76500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3040 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19310 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 425 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 544 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS B 112 REMARK 465 PRO B 113 REMARK 465 PRO B 114 REMARK 465 GLU B 115 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 11 75.42 -69.49 REMARK 500 GLN A 67 106.21 78.25 REMARK 500 ASP A 171 106.86 -166.40 REMARK 500 ASP A 209 -93.57 -101.35 REMARK 500 GLU A 210 -68.27 -143.23 REMARK 500 ASN B 11 80.64 -62.78 REMARK 500 ARG B 13 -72.52 -65.68 REMARK 500 GLN B 67 109.87 80.25 REMARK 500 ARG B 131 -63.23 -124.30 REMARK 500 ASP B 171 98.24 -177.14 REMARK 500 LYS B 211 -83.98 -51.14 REMARK 500 SER B 212 -16.70 -47.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LZ6 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LZ6 B 301 DBREF 4HJ2 A 4 220 UNP P08263 GSTA1_HUMAN 4 220 DBREF 4HJ2 B 4 220 UNP P08263 GSTA1_HUMAN 4 220 SEQRES 1 A 217 LYS PRO LYS LEU HIS TYR PHE ASN ALA ARG GLY ARG MET SEQRES 2 A 217 GLU SER THR ARG TRP LEU LEU ALA ALA ALA GLY VAL GLU SEQRES 3 A 217 PHE GLU GLU LYS PHE ILE LYS SER ALA GLU ASP LEU ASP SEQRES 4 A 217 LYS LEU ARG ASN ASP GLY TYR LEU MET PHE GLN GLN VAL SEQRES 5 A 217 PRO MET VAL GLU ILE ASP GLY MET LYS LEU VAL GLN THR SEQRES 6 A 217 ARG ALA ILE LEU ASN TYR ILE ALA SER LYS TYR ASN LEU SEQRES 7 A 217 TYR GLY LYS ASP ILE LYS GLU ARG ALA LEU ILE ASP MET SEQRES 8 A 217 TYR ILE GLU GLY ILE ALA ASP LEU GLY GLU MET ILE LEU SEQRES 9 A 217 LEU LEU PRO VAL CYS PRO PRO GLU GLU LYS ASP ALA LYS SEQRES 10 A 217 LEU ALA LEU ILE LYS GLU LYS ILE LYS ASN ARG TYR PHE SEQRES 11 A 217 PRO ALA PHE GLU LYS VAL LEU LYS SER HIS GLY GLN ASP SEQRES 12 A 217 TYR LEU VAL GLY ASN LYS LEU SER ARG ALA ASP ILE HIS SEQRES 13 A 217 LEU VAL GLU LEU LEU TYR TYR VAL GLU GLU LEU ASP SER SEQRES 14 A 217 SER LEU ILE SER SER PHE PRO LEU LEU LYS ALA LEU LYS SEQRES 15 A 217 THR ARG ILE SER ASN LEU PRO THR VAL LYS LYS PHE LEU SEQRES 16 A 217 GLN PRO GLY SER PRO ARG LYS PRO PRO MET ASP GLU LYS SEQRES 17 A 217 SER LEU GLU GLU ALA ARG LYS ILE PHE SEQRES 1 B 217 LYS PRO LYS LEU HIS TYR PHE ASN ALA ARG GLY ARG MET SEQRES 2 B 217 GLU SER THR ARG TRP LEU LEU ALA ALA ALA GLY VAL GLU SEQRES 3 B 217 PHE GLU GLU LYS PHE ILE LYS SER ALA GLU ASP LEU ASP SEQRES 4 B 217 LYS LEU ARG ASN ASP GLY TYR LEU MET PHE GLN GLN VAL SEQRES 5 B 217 PRO MET VAL GLU ILE ASP GLY MET LYS LEU VAL GLN THR SEQRES 6 B 217 ARG ALA ILE LEU ASN TYR ILE ALA SER LYS TYR ASN LEU SEQRES 7 B 217 TYR GLY LYS ASP ILE LYS GLU ARG ALA LEU ILE ASP MET SEQRES 8 B 217 TYR ILE GLU GLY ILE ALA ASP LEU GLY GLU MET ILE LEU SEQRES 9 B 217 LEU LEU PRO VAL CYS PRO PRO GLU GLU LYS ASP ALA LYS SEQRES 10 B 217 LEU ALA LEU ILE LYS GLU LYS ILE LYS ASN ARG TYR PHE SEQRES 11 B 217 PRO ALA PHE GLU LYS VAL LEU LYS SER HIS GLY GLN ASP SEQRES 12 B 217 TYR LEU VAL GLY ASN LYS LEU SER ARG ALA ASP ILE HIS SEQRES 13 B 217 LEU VAL GLU LEU LEU TYR TYR VAL GLU GLU LEU ASP SER SEQRES 14 B 217 SER LEU ILE SER SER PHE PRO LEU LEU LYS ALA LEU LYS SEQRES 15 B 217 THR ARG ILE SER ASN LEU PRO THR VAL LYS LYS PHE LEU SEQRES 16 B 217 GLN PRO GLY SER PRO ARG LYS PRO PRO MET ASP GLU LYS SEQRES 17 B 217 SER LEU GLU GLU ALA ARG LYS ILE PHE HET LZ6 A 301 38 HET LZ6 B 301 38 HETNAM LZ6 L-GAMMA-GLUTAMYL-S-(2-{[4-(3-CARBOXYPROPYL)PHENYL](2- HETNAM 2 LZ6 CHLOROETHYL)AMINO}ETHYL)-L-CYSTEINYLGLYCINE HETSYN LZ6 CHLORAMBUCIL-GLUTATHIONE CONJUGATE FORMUL 3 LZ6 2(C24 H35 CL N4 O8 S) FORMUL 5 HOH *298(H2 O) HELIX 1 1 MET A 16 ALA A 26 1 11 HELIX 2 2 SER A 37 ASP A 47 1 11 HELIX 3 3 GLN A 67 TYR A 79 1 13 HELIX 4 4 ASP A 85 LEU A 108 1 24 HELIX 5 5 PRO A 113 GLU A 115 5 3 HELIX 6 6 GLU A 116 ARG A 131 1 16 HELIX 7 7 ARG A 131 GLY A 144 1 14 HELIX 8 8 SER A 154 ASP A 171 1 18 HELIX 9 9 PHE A 178 ASN A 190 1 13 HELIX 10 10 LEU A 191 GLN A 199 1 9 HELIX 11 11 GLU A 210 PHE A 220 1 11 HELIX 12 12 ARG B 13 ARG B 15 5 3 HELIX 13 13 MET B 16 ALA B 26 1 11 HELIX 14 14 SER B 37 ASP B 47 1 11 HELIX 15 15 GLN B 67 TYR B 79 1 13 HELIX 16 16 ASP B 85 LEU B 109 1 25 HELIX 17 17 LYS B 117 ARG B 131 1 15 HELIX 18 18 ARG B 131 GLY B 144 1 14 HELIX 19 19 SER B 154 ASP B 171 1 18 HELIX 20 20 PHE B 178 LEU B 191 1 14 HELIX 21 21 LEU B 191 GLN B 199 1 9 HELIX 22 22 ASP B 209 PHE B 220 1 12 SHEET 1 A 4 GLU A 31 ILE A 35 0 SHEET 2 A 4 LYS A 6 PHE A 10 1 N LEU A 7 O GLU A 31 SHEET 3 A 4 MET A 57 ILE A 60 -1 O MET A 57 N HIS A 8 SHEET 4 A 4 MET A 63 VAL A 66 -1 O LEU A 65 N VAL A 58 SHEET 1 B 4 GLU B 31 ILE B 35 0 SHEET 2 B 4 LYS B 6 PHE B 10 1 N TYR B 9 O ILE B 35 SHEET 3 B 4 MET B 57 ILE B 60 -1 O MET B 57 N HIS B 8 SHEET 4 B 4 MET B 63 VAL B 66 -1 O LEU B 65 N VAL B 58 CISPEP 1 VAL A 55 PRO A 56 0 0.20 CISPEP 2 VAL B 55 PRO B 56 0 0.06 SITE 1 AC1 17 TYR A 9 ARG A 15 ARG A 45 GLN A 54 SITE 2 AC1 17 VAL A 55 GLN A 67 THR A 68 ILE A 106 SITE 3 AC1 17 LEU A 107 PRO A 110 MET A 208 PHE A 220 SITE 4 AC1 17 HOH A 447 HOH A 494 ASP B 101 ARG B 131 SITE 5 AC1 17 HOH B 449 SITE 1 AC2 18 ASP A 101 ARG A 131 HOH A 495 TYR B 9 SITE 2 AC2 18 ARG B 15 ARG B 45 GLN B 54 VAL B 55 SITE 3 AC2 18 GLN B 67 THR B 68 ILE B 106 LEU B 107 SITE 4 AC2 18 PRO B 110 MET B 208 PHE B 220 HOH B 458 SITE 5 AC2 18 HOH B 477 HOH B 508 CRYST1 99.000 93.530 51.180 90.00 93.91 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010101 0.000000 0.000690 0.00000 SCALE2 0.000000 0.010692 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019584 0.00000